Terms: = Kidney tumors AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
66 results:
1. Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker.
Zainodini N; Abolhasani M; Mohsenzadegan M; Farajollahi MM; Rismani E
J Cancer Res Clin Oncol; 2024 Mar; 150(3):165. PubMed ID: 38546751
[TBL] [Abstract] [Full Text] [Related]
2. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Merseburger AS; Attard G; Åström L; Matveev VB; Bracarda S; Esen A; Feyerabend S; Senkus E; López-Brea Piqueras M; Boysen G; Gourgioti G; Martins K; Chowdhury S
Lancet Oncol; 2022 Nov; 23(11):1398-1408. PubMed ID: 36265504
[TBL] [Abstract] [Full Text] [Related]
3. A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That
Wang Y; Li C; Qi X; Yao Y; Zhang L; Zhang G; Xie L; Wang Q; Zhu W; Guo X
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955933
[TBL] [Abstract] [Full Text] [Related]
4. Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
Eggers H; Schünemann C; Grünwald V; Rudolph L; Tiemann ML; Reuter C; Anders-Meyn MF; Ganser A; Ivanyi P
World J Urol; 2022 Oct; 40(10):2489-2497. PubMed ID: 35916904
[TBL] [Abstract] [Full Text] [Related]
5. Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality.
Li P; Chen T; Kuang P; Liu F; Li Z; Liu F; Wang Y; Zhang W; Cai X
Cell Death Dis; 2022 Jul; 13(7):606. PubMed ID: 35831273
[TBL] [Abstract] [Full Text] [Related]
6. Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells.
Freitas AS; Costa M; Pontes O; Seidel V; Proença F; Cardoso SM; Oliveira R; Baltazar F; Almeida-Aguiar C
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807247
[TBL] [Abstract] [Full Text] [Related]
7. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract] [Full Text] [Related]
8. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
[TBL] [Abstract] [Full Text] [Related]
9. A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma.
Kato T; Tomiyama E; Koh Y; Matsushita M; Hayashi Y; Nakano K; Ishizuya YU; Wang C; Hatano K; Kawashima A; Ujike T; Kawasaki K; Morii E; Gotoh K; Eguchi H; Kiyotani K; Fujita K; Nonomura N; Uemura M
Anticancer Res; 2020 Sep; 40(9):4875-4883. PubMed ID: 32878775
[TBL] [Abstract] [Full Text] [Related]
10. Transition from open partial nephrectomy directly to robotic surgery: experience of a single surgeon to achieve "TRIFECTA".
Castilho TML; Lemos GC; Cha JD; Colombo JR; Claros OR; Lemos MB; Carneiro A
Int Braz J Urol; 2020; 46(5):814-821. PubMed ID: 32648421
[TBL] [Abstract] [Full Text] [Related]
11. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract] [Full Text] [Related]
12. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
[TBL] [Abstract] [Full Text] [Related]
13. Can CpG methylation serve as surrogate markers for immune infiltration in cancer?
Bacolod MD; Barany F; Fisher PB
Adv Cancer Res; 2019; 143():351-384. PubMed ID: 31202362
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
[TBL] [Abstract] [Full Text] [Related]
15. An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade.
Zhao W; Zhao F; Yang K; Lu Y; Zhang Y; Wang W; Xie H; Deng K; Yang C; Rong Z; Hou Y; Li K
J Cell Biochem; 2019 Aug; 120(8):13330-13341. PubMed ID: 30916827
[TBL] [Abstract] [Full Text] [Related]
16. Addressable Peptide Self-Assembly on the Cancer Cell Membrane for Sensitizing Chemotherapy of Renal Cell Carcinoma.
Wang Z; An HW; Hou D; Wang M; Zeng X; Zheng R; Wang L; Wang K; Wang H; Xu W
Adv Mater; 2019 Mar; 31(11):e1807175. PubMed ID: 30663139
[TBL] [Abstract] [Full Text] [Related]
17. One-tailed asymptotic inferences for the difference of proportions: Analysis of 97 methods of inference.
Hernández MÁ; Andrés AM; Tejedor IH
J Biopharm Stat; 2018; 28(6):1090-1104. PubMed ID: 29608389
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model.
Hardiansyah D; Attarwala AA; Kletting P; Mottaghy FM; Glatting G
Phys Med; 2017 Oct; 42():298-304. PubMed ID: 28739143
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of potential miRNA biomarkers of VERO-cell tumorigenicity in a new line (AGMK1-9T7) of African green monkey kidney cells.
Teferedegne B; Rotroff DM; Macauley J; Foseh G; Lewis G; Motsinger-Rief A; Lewis AM
Vaccine; 2017 Oct; 35(41):5503-5509. PubMed ID: 28434690
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
[TBL] [Abstract] [Full Text] [Related]
[Next]
